FILED! Remdesivir Class Action Lawsuit Against Gilead Science Inc. Alleges False Advertising And Negligence

And that's why it's known as "Run! Death is Near!"

Dr Margaret Aranda

Oct 02, 2023

∙ Paid

Thank you to my Twitter/X friend @Shea1938, who alerted me to this crucial lawsuit filing.

Share The Rebel Patient™

Background

Remdesivir is the only FDA-approved antiviral therapy that was used only in hospitalized patients under official protocols that were automated in hospital electronic medical records.

While the intravenous concoction was also pushed by Fauci and many doctors and nurses who failed to warn of its risks, Gilead is the only defendant named in this suit.

On July 31, 2023, my article reviewed the alarming news that FDA’s newest criteria allowed Remdesivir’s use in patients with kidney failure, even those on dialysis:

Medical Freedom

The FDA Approves Gilead Science's Remdesivir for All Stages of Kidney Disease including Dialysis, and Removes Precaution to Check for Bleeding and Liver Damage Before and During Use

Dr Margaret Aranda

July 31, 2023

The FDA Approves Gilead Science's Remdesivir for All Stages of Kidney Disease including Dialysis, and Removes Precaution to Check for Bleeding and Liver Damage Before and During Use

In an incredible and in-your-face move, on July 14, 2023, the FDA quietly approved Gilead’s Veklury (AKA remdesivir or RUN DEATH IS NEAR) for Covid-19 patients who have severe renal impairment. It is now approved for patients who are either 1) hospitalized or 2) not hospitalized but at high risk for COVID sequelae or death; and 3) does not require labs to check for bleeding or liver damage prior to or during use.

Read full story

Remdesivir Use in Ontario, Canada

The use of Remdesivir continues unabated, seemingly extending to outpatient facilities in the US, and all over the world.

Keep reading with a 7-day free trial

Subscribe to The Rebel Patient™ to keep reading this post and get 7 days of free access to the full post archives.